← Open Payments lookup

MADELEINE VERDOLINO: Open Payments

NPI 1538800123 · ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,558 in 121 payments from 13 companies in 2025. Trend: 2023 $1,355 · 2024 $1,941 · 2025 $2,558

Food & beverage: $2,558
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.34$679
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$340
ABBVIE INC.17$296
Teva Pharmaceuticals USA, Inc.6$237
Alkermes, Inc.12$218
Janssen Pharmaceuticals, Inc11$206
Braeburn Inc.3$129
Indivior Inc.5$127
Neurocrine BioSciences, Inc.5$125
E.R. Squibb & Sons, L.L.C.4$96

Products named: REXULTI, CAPLYTA, VRAYLAR, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR, BRIXADI, SUBLOCADE.

Industry payments across MA — which companies pay providers there.